AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

QUAD-HF - Prospective Registry of Patients With Incident Heart Failure and Left Ventricular Ejection Fraction <50%

Recruitingn/aAges 18 Years - anyAllMid and South Essex NHS Foundation Trust
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The QUAD-HF registry is an observational study that would enroll patients in the United Kingdom, who have been newly diagnosed with heart failure and a left ventricular ejection fraction \<50%. We plan to assess clinical outcomes in these patients, such as hospitalization and death, in relation to their diagnosis, implementation of guidelines and type of treatments these patients have received.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: 1. Age \>18 years 2. Newly diagnosed Heart Failure with a Left Ventricular Ejection Fraction \<50% (โ‰ค12 Weeks prior to enrolment). 3. Able and willing to consent. Exclusion Criteria: 1. LVEF 50% or more at time of diagnosis 2. Palliative care 3. Unable or unwilling to give consent
๐Ÿ’Š

What it tests

  • Not listed
๐Ÿ“

Where

2 sites
Mid and South Essex NHS Foundation Trust
Basildon, United Kingdom
British Heart Foundation Glasgow Cardiovascular Research Centre, Glasgow
Glasgow, United Kingdom
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy